About: Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $15.42 (-2.22%)
DYN NASDAQ Dyne Therapeutics Inc
Dyne Therapeutics Inc share price
Atividade de preço de DYN
Último preço
$ 15,470
Variação (24h)
-0,30 USD (1,92%)
Volume
776.71K
Volume (média 4 sem.)
-
Abertura
$ 15,56
Variação do dia
$ 15,32 - $ 15,92
Fechamento anterior
$ 15,77
Último negócio
23 Oct, 6:28 pm GMT+0
Atrasado
23 Oct, 6:28 pm GMT+0
DYN price performance
Atrasado
23 Oct, 6:28 pm GMT+0
quote.marketSignals